Y-Intercept (HK)’s Nautilus Biotechnolgy NAUT Stock Holding History

Y-Intercept (HK)’s Portfolio NAUT Stock Details NAUT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-58,152	Closed	-$109K	–	1918
2026 Q2	$109K	Buy	+58,152	New	+$154K	﹤0.01%	1607
2025 Q3	–	Sell	-224,456	Closed	-$163K	–	1869
2025 Q2	$163K	Buy	+224,456	New	+$169K	﹤0.01%	1489
2024 Q4	–	Sell	-12,404	Closed	-$35.4K	–	1496
2024 Q3	$35.4K	Sell	12,404 -11,512	-48%	-$29.8K	﹤0.01%	1231
2024 Q2	$56K	Buy	+23,916	New	+$62.4K	﹤0.01%	1295
2022 Q2	–	Sell	-16,106	Closed	-$70K	–	1079
2022 Q1	$70K	Buy	+16,106	New	+$66.1K	0.02%	688

Other funds holding NAUT

Hillman Company Pittsburgh, Pennsylvania $261M AUM 2.04% 1-Year Est. Return

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return

Badgley Phelps Wealth Managers Seattle, Washington $5.8B AUM 25.34% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Apollon Wealth Management Mount Pleasant, South Carolina $8.72B AUM 23.07% 1-Year Est. Return

Vanguard Capital Wealth Advisors Denver, Colorado $145M AUM 65.64% 1-Year Est. Return

Garde Capital Seattle, Washington $1.8B AUM 11.9% 1-Year Est. Return

BFSG LLC Irvine, California $1.14B AUM 21.04% 1-Year Est. Return

Y-Intercept (HK)'s NAUT Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Nautilus Biotechnolgy (NAUT) in Q3 2026, closing a stake of 58,152 shares — an estimated $109K sold.

Y-Intercept (HK) first reported a position in NAUT in Q1 2022 and held it in 5 quarters. The position peaked at $163K in Q2 2025. 15 funds tracked by Wall St. Rank hold NAUT as of Q3 2026.

Y-Intercept (HK) reported no remaining Nautilus Biotechnolgy position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 58,152 Nautilus Biotechnolgy shares in Q3 2026, an estimated $109K.
Y-Intercept (HK) first reported a position in Nautilus Biotechnolgy in Q1 2022 and held it in 5 quarters.
Y-Intercept (HK)'s Nautilus Biotechnolgy position peaked at $163K in Q2 2025.
15 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.